I know that Don spoke to several shareholders, on this Hub and others following AGMs. Nothing ever comes to fruition.

I believe that Don was only interested in the expansion of licensing agreements, i.e., Hepalink. But now we are faced with reality. Topline failed.

In my opinion, without Topline, it has made it harder for Don to licence apabetalone and that much harder for an outright sale of the business, let alone financing it. I hope that the cognitive impairment sub-study shows positive to keep things alive.

IMO....Koo